Vaxart, Inc. - Common Stock
Long
Mis à jour

At Long Term Support. Revenue Beat. 682% Upside.

266
We are right at the support line spanning across 5 years. With revenue beat and 682% upside (average price target), it looks like a safe buy. I hold stocks and April 2025 calls.
Transaction en cours
Fib level .382 roughly coincides with the analyst's average price target.
Note
Still above the trend line.
Note
Above 50 SMA yet again on the weekly. Not it should stay there and challenge 200 SMA.

snapshot
Note
Note: It has made multiple attempts in the past to challenge the 50 SMA but has failed. However, the base held (yellow line).

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.